Literature DB >> 22142811

Differentiation-promoting culture of competent and noncompetent keratinocytes identifies biomarkers for head and neck cancer.

Rebecca Ceder1, Ylva Haig, Marina Merne, Annette Hansson, Xi Zheng, Karin Roberg, Matthias Nees, Kristiina Iljin, Balvinder K Bloor, Peter R Morgan, Bengt Fadeel, Roland C Grafström.   

Abstract

Aberrant contact-inhibited proliferation and differentiation induction couple with tumor severity, albeit with an imprecise association with prognosis. Assessment of contact inhibition and differentiation-promoting culture in this study of normal and immortalized oral keratinocytes (NOK and SVpgC2a, respectively) demonstrated elevated cloning ability and saturation density in the immortalized versus normal state, including consistent absence of differentiated morphological features. Transcriptomic analysis implicated 48 gene ontology categories, 8 molecular networks, and 10 key regulator genes in confluency-induced differentiation of NOK, all of which remained nonregulated in SVpgC2a. The SVpgC2a versus NOK transcriptome enriched 52 gene ontology categories altogether, 18 molecular networks, and 39 key regulator genes, several of which were associated with epithelial-mesenchymal transition. Assessment of the previously described gene sets relative to training data sets of head and neck squamous cell carcinoma samples, one including data on tumor differentiation and patient outcome and one present in the Human Gene Expression Map, identified four genes with association to poor survival (COX7A1, MFAP5, MPDU1, and POLD1). This gene set predicted poor outcome in an independent data set of 71 head and neck squamous cell carcinomas. The present study defines, for the first time to our knowledge, the broad gene spectrum that couples to induction, and loss, of oral keratinocyte differentiation. Bioinformatics assessments of the results relative to clinical data generated novel differentiation-related tumor biomarkers relevant to patient outcome.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142811     DOI: 10.1016/j.ajpath.2011.10.016

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Serum-induced differentiation of human meibomian gland epithelial cells.

Authors:  David A Sullivan; Yang Liu; Wendy R Kam; Juan Ding; Karin M Green; Scott A Shaffer; Mark P Hatton; Shaohui Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-27       Impact factor: 4.799

Review 2.  Microfibril-associated glycoproteins MAGP-1 and MAGP-2 in disease.

Authors:  Clarissa S Craft; Thomas J Broekelmann; Robert P Mecham
Journal:  Matrix Biol       Date:  2018-03-07       Impact factor: 11.583

Review 3.  The microfibril-associated glycoproteins (MAGPs) and the microfibrillar niche.

Authors:  Robert P Mecham; Mark A Gibson
Journal:  Matrix Biol       Date:  2015-05-08       Impact factor: 11.583

4.  Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma.

Authors:  Lei Zhao; Maria Westerhoff; Jason L Hornick; Thomas Krausz; Tatjana Antic; Shu-Yuan Xiao; John Hart
Journal:  Virchows Arch       Date:  2019-08-18       Impact factor: 4.064

5.  Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples.

Authors:  Jean-Baptiste Bachet; Séverine Tabone-Eglinger; Sophie Dessaux; Anthony Besse; Sabrina Brahimi-Adouane; Jean-François Emile; Jean-Yves Blay; Laurent Alberti
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

6.  Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.

Authors:  Ali Khammanivong; Brent S Sorenson; Karen F Ross; Erin B Dickerson; Rifat Hasina; Mark W Lingen; Mark C Herzberg
Journal:  Oncotarget       Date:  2016-03-22

Review 7.  Biological Networks for Cancer Candidate Biomarkers Discovery.

Authors:  Wenying Yan; Wenjin Xue; Jiajia Chen; Guang Hu
Journal:  Cancer Inform       Date:  2016-09-04

8.  MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer.

Authors:  Xi Yang; Kailiu Wu; Siyi Li; Longwei Hu; Jing Han; Dongwang Zhu; Xuerui Tian; Wei Liu; Zhen Tian; Laiping Zhong; Ming Yan; Chenping Zhang; Zhiyuan Zhang
Journal:  Oncotarget       Date:  2017-01-10

9.  Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma.

Authors:  Salvatore Alfieri; Andrea Carenzo; Francesca Platini; Mara S Serafini; Federica Perrone; Donata Galbiati; Andrea P Sponghini; Roberta Depenni; Andrea Vingiani; Pasquale Quattrone; Edoardo Marchesi; Maria F Iannó; Arianna Micali; Elisa Mancinelli; Ester Orlandi; Sara Marceglia; Laura D Locati; Lisa Licitra; Paolo Bossi; Loris De Cecco
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

10.  Elevated expression of POLD1 is associated with poor prognosis in breast cancer.

Authors:  Qinghong Qin; Qixing Tan; Jinyuan Li; Weiping Yang; Bin Lian; Qinguo Mo; Changyuan Wei
Journal:  Oncol Lett       Date:  2018-09-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.